244 related articles for article (PubMed ID: 19446624)
1. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.
Simard P; Leroux JC
Int J Pharm; 2009 Nov; 381(2):86-96. PubMed ID: 19446624
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of pH-sensitive polymer-based immunoliposomes targeting the CD33 antigen.
Simard P; Leroux JC
Mol Pharm; 2010 Aug; 7(4):1098-107. PubMed ID: 20476756
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs.
Connor J; Huang L
Cancer Res; 1986 Jul; 46(7):3431-5. PubMed ID: 2871923
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR
Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian L; Ball ED
Exp Hematol; 2005 Feb; 33(2):199-211. PubMed ID: 15676214
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
[TBL] [Abstract][Full Text] [Related]
7. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells.
Matthay KK; Abai AM; Cobb S; Hong K; Papahadjopoulos D; Straubinger RM
Cancer Res; 1989 Sep; 49(17):4879-86. PubMed ID: 2788031
[TBL] [Abstract][Full Text] [Related]
8. Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.
Matthay KK; Heath TD; Badger CC; Bernstein ID; Papahadjopoulos D
Cancer Res; 1986 Oct; 46(10):4904-10. PubMed ID: 3756852
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems.
Rothdiener M; Müller D; Castro PG; Scholz A; Schwemmlein M; Fey G; Heidenreich O; Kontermann RE
J Control Release; 2010 Jun; 144(2):251-8. PubMed ID: 20184933
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells.
Carrion C; de Madariaga MA; Domingo JC
Life Sci; 2004 Jun; 75(3):313-28. PubMed ID: 15135652
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
12. Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.
Roux E; Francis M; Winnik FM; Leroux JC
Int J Pharm; 2002 Aug; 242(1-2):25-36. PubMed ID: 12176222
[TBL] [Abstract][Full Text] [Related]
13. Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents.
Chen T; McIntosh D; He Y; Kim J; Tirrell DA; Scherrer P; Fenske DB; Sandhu AP; Cullis PR
Mol Membr Biol; 2004; 21(6):385-93. PubMed ID: 15764368
[TBL] [Abstract][Full Text] [Related]
14. CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted flow-cytometric detection of acute myeloid leukaemia.
Retnakumari A; Jayasimhan J; Chandran P; Menon D; Nair S; Mony U; Koyakutty M
Nanotechnology; 2011 Jul; 22(28):285102. PubMed ID: 21654031
[TBL] [Abstract][Full Text] [Related]
15. Steric stabilization of liposomes by pH-responsive N-isopropylacrylamide copolymer.
Roux E; Stomp R; Giasson S; Pézolet M; Moreau P; Leroux JC
J Pharm Sci; 2002 Aug; 91(8):1795-802. PubMed ID: 12115806
[TBL] [Abstract][Full Text] [Related]
16. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
17. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Chen J; Zhou JH; Ball ED
Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
[TBL] [Abstract][Full Text] [Related]
18. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
Fattal E; Couvreur P; Dubernet C
Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
[TBL] [Abstract][Full Text] [Related]
19. Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes.
Meyer O; Papahadjopoulos D; Leroux JC
FEBS Lett; 1998 Jan; 421(1):61-4. PubMed ID: 9462840
[TBL] [Abstract][Full Text] [Related]
20. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
Pan X; Lee RJ
Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
